
<oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:title>Methyldopa in the Treatment of Hypertension</dc:title>
  <dc:subject>Hypertension</dc:subject>
  <dc:subject>Antihypertensive Agents</dc:subject>
  <dc:subject>Methyldopa</dc:subject>
  <dc:description>In this paper, Freis evaluated the newly developed ganglion-blocking agent, methyldopa. He reported that it exhibited fewer side effects than a similar drug, guanethidine, yet it was not favored by patients since it required them to take a larger number of tablets at a greater frequency.</dc:description>
  <dc:publisher>Medical Society of the District of Columbia, January 1965</dc:publisher>
  <dc:publisher>The Medical Society of the District of Columbia, January 1965</dc:publisher>
  <dc:contributor>The Medical Annals of the District of Columbia</dc:contributor>
  <dc:contributor>Gilmore, Bruce L.</dc:contributor>
  <dc:contributor>Freis, Edward D.</dc:contributor>
  <dc:type>Articles</dc:type>
  <dc:format>Archival Materials</dc:format>
  <dc:format>Text</dc:format>
  <dc:format>6 pages</dc:format>
  <dc:identifier>nlm:nlmuid-101584929X110-doc</dc:identifier>
  <dc:identifier>101584929X110</dc:identifier>
  <dc:identifier>http://resource.nlm.nih.gov/101584929X110</dc:identifier>
  <dc:identifier>Profiles ID: XFBBHJ</dc:identifier>
  <dc:language>English</dc:language>
  <dc:relation>Profiles in Science</dc:relation>
</oai_dc:dc>